Last Updated on January 3, 2024 by The Health Master
Mumbai: Drug maker Lupin is recalling 5,720 tubes of a cream used in the treatment of various skin conditions, such as dermatitis, eczema, and psoriasis, from the US market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).
According to the most recent Enforcement Report by the US health regulator, the Mumbai-based drug manufacturer, Lupin Pharmaceuticals Inc., is recalling Clobetasol propionate Cream, a steroid used to treat skin irritation by reducing inflammation, redness, and itching.
The affected lot has been manufactured at the company’s Pithampur plant in Madhya Pradesh and marketed in the US market by Baltimore-based Lupin Pharmaceuticals Inc.
The USFDA noted that the company is recalling the affected lot due to “subpotent drug: low assay result observed during long-term stability testing.”
The company initiated the Class III nationwide (US) recall of the affected lot on January 23 this year.
As per the USFDA, a class III recall is initiated in a “situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.”
In 2019, the US generic drug market is expected to be worth approximately USD 115.2 billion. It is the largest market for pharmaceutical products.
Drug recall: These Lots of Levothyroxine sodium Oral Solution recalled
Drug recall: Bharat Biotech voluntarily recalls ChiroRaba vaccine due to this reason
Drug recall: Rifampin Capsules recalled due to this reason
Drug recall: Epinephrine API recalled due to this reason
Drug recall: Daptomycin for Injection recalled due to this reason
Drug recall: Vancomycin Hydrochloride Injection recalled due to this reason
NPPA revised Ceiling price of 53 scheduled formulations: February 2023
Pharma companies restrained from making Diabetes drug
India to spend $79.6 million to strengthen Drug Regulatory system
Drug recall: These Lots of Levothyroxine sodium Oral Solution recalled
NPPA fixed retail price of 18 formulations: February 2023
FDA Chhattisgarh raided various places and seized huge quantity of fake medicines
Latest IPC Alert – Indian Pharmacopoeia Commission
NSQ Drug: Route cause analysis and CAPA
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
